U.S., Jan. 14 -- ClinicalTrials.gov registry received information related to the study (NCT07337876) titled 'Organ Preservation in Rectal Cancer by Dose Escalated MR Guided Adaptive Radiotherapy' on Jan. 01.
Brief Summary: This study is testing whether radiation delivered with MRI guidance using a so-called MR-linac in distal rectal cancer can result in a high rate of organ preservation. Patients will receive radiotherapy together with standard chemotherapy.
Study Start Date: Jan. 07
Study Type: INTERVENTIONAL
Condition:
Rectal Cancer
Intervention:
RADIATION: Dose escalated radiotherapy using a 1.5 T MR-Linac
Dose escalated radiotherapy using a 1.5 T MR-Linac is given to the primary tumor and affected lymph nodes in an online adapti...